Angiotensin type 1 receptor antagonists/hydrochlorothiazidePurpuric eruption: 4 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2014年 / 1500卷 / 1期
关键词：
D O I：
10.1007/s40278-014-0597-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 7
相关论文
共 50 条
  • [21] Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension
    Birkenhäger, WH
    de Leeuw, PW
    JOURNAL OF HYPERTENSION, 1999, 17 (07) : 873 - 881
  • [22] Angiotensin type 1 receptor antagonists induce PPARgamma activation in human adipose
    Janke, J
    Schupp, M
    Engeli, S
    Gorzelniak, K
    Said, L
    Nystrom, FH
    Luft, FC
    Sharma, AM
    HYPERTENSION, 2005, 46 (04) : 823 - 823
  • [23] Angiotensin type 1 receptor antagonists induce induce PPAR gamma activity
    Schupp, M
    Janke, J
    Clasen, R
    Unger, T
    Kintscher, U
    JOURNAL OF HYPERTENSION, 2004, 22 : S151 - S151
  • [24] Comparison of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Essential Hypertension
    David H. G. Smith
    Drugs, 2008, 68 : 1207 - 1225
  • [25] Molecular activation of PPARγ by angiotensin II type 1-receptor antagonists
    Erbe, David V.
    Gartrell, Katherine
    Zhang, Yan-Ling
    Suri, Vipin
    Kirincich, Steven J.
    Will, Sarah
    Perreault, Mylene
    Wang, Suyue
    Tobin, James F.
    VASCULAR PHARMACOLOGY, 2006, 45 (03) : 154 - 162
  • [26] Comparison of angiotensin II type 1 receptor antagonists in the treatment of essential hypertension
    Smith, David H. G.
    DRUGS, 2008, 68 (09) : 1207 - 1225
  • [27] Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents
    Herder, Siegtraut Dorothea
    Weber, Ernst
    Winkemann, Almuth
    Herder, Christoph
    Morck, Hartmut
    PEDIATRIC NEPHROLOGY, 2010, 25 (05) : 801 - 811
  • [28] The Role of Angiotensin II Type 1 Receptor Antagonists in Elderly Patients with Hypertension
    G. Neil Thomas
    Paul Chan
    Brian Tomlinson
    Drugs & Aging, 2006, 23 : 131 - 155
  • [29] Dopamine D2-receptor antagonists/lithiumCatatonia: 4 case reports
    Reactions Weekly, 2019, 1761 (1) : 145 - 145
  • [30] Botulinum toxin/cholinergic receptor antagonists/levodopaLack of efficacy: 4 case reports
    Reactions Weekly, 2022, 1908 (1) : 128 - 128
12345